XBITXBiotech Inc

CSNasdaq (XNAS)·USD

Identity

Security key: 23828
Ticker: XBIT
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2015-04-15
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: XBIT

Detail

Enriched 2026-08-14 20:47

Market cap: $74,999,818.26
Shares outstanding (class): 30,487,731
Shares outstanding (weighted): 30,487,731
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 87
Location: AUSTIN, TX
Homepage: http://www.xbiotech.com
Description: XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Market cap and share counts drift.

Funds holding this security

7 funds · 7 positions · $728.0K reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$472.3K	0.00%	200,971 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$122.9K	0.01%	52,317 NS	FIGI
Ultra-Small Company Fund Bridgeway Funds, Inc.	—	$91.4K	0.11%	38,900 NS	FIGI
JNL/DFA U.S. Small Cap Fund JNL Series Trust	—	$14.3K	0.00%	6,066 NS	FIGI
Small Cap Core Fund Northern Funds	—	$11.8K	0.00%	5,012 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$9.1K	0.01%	3,866 NS	FIGI
AST Small-Cap Equity Portfolio Advanced Series Trust	—	$6.3K	0.00%	2,660 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERXBIT
FIGI_COMPOSITEBBG0081S8D39
FIGI_SHARE_CLASSBBG0081S8D48
CIK0001626878
ISINCA98400H1029
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: XBiotech is a biopharmaceutical company developing antibody therapies, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.